Podimetrics

Founded in 2011, Podimetrics has developed a clinically validated, virtual care solution for high-risk diabetic patients, centered on preventing amputations and hospitalizations. Its technology platform, led by the SmartMat, detects early signs of foot inflammation, triggering timely clinical intervention. The company is commercial, generating revenue through partnerships with health plans and health systems, and is positioned to address a significant cost burden within the diabetes care continuum.

The SmartMat, an FDA-cleared connected health mat that uses thermal imaging to detect foot inflammation, paired with a clinical analytics platform and care coordination service for early intervention.

Podimetrics competes in the digital diabetes management and remote patient monitoring space. Direct competitors may include other smart mat technologies or connected insole solutions. Indirect competition comes from broader telehealth platforms, traditional podiatry care, and diabetes management apps. Its key differentiator is its specific, clinically validated focus on preventing amputations with an integrated device-and-service model.